and courier for potential self-administration. The clinical study includes 258 healthy participants between the ages of 18 and 50 years, making it the largest Phase I trial conducted-to-date by Vaxxas with its HD-MAP technology. The trial will...
chemotherapy for the first-line treatment of adult patients with non-squamous NSCLC whose tumors have PD-L1 expression on ≥50% of tumor cells with no EGFR or ALK positive mutations and who have locally advanced NSCLC and are not candidates for...
(FDA) will hold an advisory committee meeting with the Cardiovascular and Renal Drugs Advisory Committee (CRDAC) on October 10, 2024 to evaluate the New Drug Application (NDA) for elamipretide, the first potential therapy for Barth syndrome. This...
homes of millions of patients and consumers around the world. Aptar is headquartered in Crystal Lake, Illinois and has over 13,000 dedicated employees in 20 countries. For more information, visit www.aptar.com.
Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, announced its collaboration with Roche to integrate Lunit SCOPE PD-L1 22C3 TPS into Roche's navify® Digital Pathology platform. This marks...
company announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to AISA-021(cilnidipine), a fourth-generation calcium channel antagonist. Aisa is developing AISA-021 for the treatment of Systemic Sclerosis...
studies conducted at MD Anderson show that the uptake of TUSC2 in tumor cells in vitro after REQORSA treatment was 10 to 33 times the uptake in normal cells. About Genprex, Inc.: Genprex, Inc. is a clinical-stage gene therapy company focused on...
Guidelines as an ancillary tool in the diagnosis and monitoring of UTUC. Bladder cancer is the sixth most common cancer[1] as there are approximately 760,000 people in Europe living with the disease[2]. Surveillance is of paramount importance for...
technology, extends its range of accessories and sensors for the award-winning HABITAT research bioreactor. This 3-in-1 bioreactor, fermenter, and photobioreactor now boasts additional tools to provide more options for today's researchers,...
volume as Carterra's first two systems while also delivering the utmost sensitivity to characterize molecules as small as 100 Daltons. Ultra boasts enhanced optics, advanced microfluidics, and thermals capable of high-sensitivity measurements in an...
FDA-approved treatment to reduce the loss of kidney function in adults with primary immunoglobulin A nephropathy (IgAN).1 Primary immunoglobulin A nephropathy (IgAN or Berger's Disease) is a rare, progressive, chronic autoimmune disease that...
the intelligence of devices – the company is everywhere. In 2023, Merck KGaA, Darmstadt, Germany, generated sales of € 21 billion in 65 countries. The company holds the global rights to the name and trademark “Merck” internationally. The only...
chemotherapy-free regimen, of adult patients with metastatic non-small cell lung cancer (NSCLC) whose tumors have EGFR exon 19 deletions of exon 21 L858R mutations, as detected by an FDA-approved test. This new regimen shows superior...
COVID vaccines from Pfizer and Moderna along with the annual flu vaccine, in anticipation of a challenging flu and COVID-19 season, as forecasted by the Centers for Disease Control and Prevention (CDC). “Albertsons Cos. pharmacies provide dedicated...
for the target host cell line as opposed to off-target DNA. The FAM-labeled nucleic acid probe is quenched by BHQ-1™ until PCR extension. The kits are compatible with any qPCR instrument that detects FAM signal, eliminating the added cost of...
CVS Health® announced that the updated 2024-2025 COVID-19 vaccines and flu vaccines are available at CVS Pharmacy® and MinuteClinic® locations nationwide. Walk-ins are being accepted at CVS Pharmacy and the company's digital vaccine scheduler has...
brain-penetrant, MAP4 kinase (MAP4K) inhibitor—and additional pipeline programs. Prosetin is being evaluated in Study PRO-101, a hybrid Phase 1 clinical trial designed to evaluate its safety, tolerability, pharmacokinetics, and pharmacodynamics in...
pathologists using their cutting edge-technology and tools in routine practice around the world. The company has seen a 157% increase in patient cases processed monthly via Ibex’s AI solution and 178% rise in new customers, reflecting its expanded...
that the U.S. Food and Drug Administration ("FDA") has cleared its Investigational New Drug ("IND") application for FTX-101, enabling the company to initiate its planned Phase 1 clinical study of FTX-101 in healthy volunteers. The company...
("Corina"), developed by Yipurun (Shanghai) Biotechnology Co., Ltd. ("YPR"), has received approval in China (G.X.Z.Z. 20243181461) for use in patients with moderate-to-severe intrauterine adhesions (IUA) who undergo transcervical resection of...
